1 / 13

Biosimilars in Rheumatology: A Practical Approach to Clinical Evaluation

This practical guide provides an in-depth understanding of biosimilars in rheumatology, including clinical evaluation, regulatory pathways, extrapolation, and interchangeability. It also discusses specific biosimilars like Erelzi (SB4) and Adalimumab Biosimilar (GP2017), highlighting the Scandinavian cost-saving model. The summary includes a list of abbreviations for easy reference.

salgados
Download Presentation

Biosimilars in Rheumatology: A Practical Approach to Clinical Evaluation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biosimilars in Rheumatology: A Practical Approach to Clinical Evaluation

  2. Background

  3. Regulatory Pathways

  4. Extrapolation

  5. Interchangeability

  6. Interchangeability (cont)

  7. Erelzi (SB4): Etanercept Biosimilar

  8. Adalimumab Biosimilar: GP2017

  9. Approved Biosimilars

  10. Scandinavian Cost-Saving Model

  11. Summary

  12. Abbreviations

  13. Abbreviations (cont)

More Related